Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

DBS Group share price drops to 6-month low as coronavirus toll rises

Singapore’s largest bank was one of many large-cap companies whose share value had suffered, in a week that was marred by grimmer coronavirus updates.

Source: Bloomberg

DBS Group, Singapore’s largest bank by market capitalisation, was last week’s most traded Singapore equity, based on IG data.

In terms of share price, the group also experienced one of the largest drops among Singapore blue-chip firms for the week ending 28 February, erasing 3.08% in value to a six-month low of S$24 per share on IG’s platform as of Monday 02 March.

Read also: Top 5 Singapore stocks most impacted by COVID-10

DBS Group’s share price drop a reflection of uncertainty

The start of a new week did not yield much better outcomes, with the stock trading below S$24.40 a share for most of Monday’s market.

The money lender was not the only victim of the rapid decline, which came after some countries reported their first coronavirus cases, and the US reported its first case ‘without a known origin’ on Thursday 27 February.

Singapore stock benchmark Straits Times Index (STI), which tracks and tallies the performance of individual listings on the Singapore Exchange – including DBS, also suffered its steepest drop since July 2019, falling 3.82% to a 14-month low of 2,992.071.

Fellow local banks, namely OCBC and UOB, also saw share price descend 3.64% and 3.62% respectively in the previous week.

Go long or short on DBS Group shares by using IG's industry-leading trading platform.

Analysts downgrade DBS share price targets

Analysts were also conservative in their recent estimates of the company’s financial and stock performance.

OCBC’s research team had maintained a ‘hold’ rating and price target of S$27.50 on DBS Group’s stocks – following its Q4 earnings report for the 2019 fiscal year – stating that it expects ‘share price performance ahead to be influenced by the Hong Kong/China outlook’.

Meanwhile, UOB Kay Hian analyst Jonathan Koh maintained a ‘buy’ rating on the stock with a price target of S$28 per share, down from S$28.65 previously, while RHB Invest gave the stock a ‘neutral rating’ and lowered its price target from S$25.80 to S$24.80 per share.

CGS-CIMB researchers were more optimistic, on the rationale that all three major Singapore banks have a guided COVID-19 revenue impact of around 2%, which they believe is ‘relatively manageable’ barring any further credit cost changes.

They have reiterated an ‘overweight’ rating on DBS Group, and is their ‘preferred pick for having the least exposure to consumer segments at risk to the virus’ of approximately S$2 billion. They also envision that the bank’s current Common Equity Tier One ratio will help to ‘support dividends’ in 2020.

Finally, Maybank Kim Eng’s Thilan Wickramasinghe wrote that DBS’ provision expenses (as per its latest guidance) were ‘significantly lower than expected’. He is of the opinion that the risks going forward may increase, especially with the COVID-19 epidemic fallout now a major factor.

As a result, he had lowered his 2020 core-earnings forecast for the company by 2% to 5%. He had also reduced his share price target for the group’s listing to S$28.60 a share from S$29.92 previously, while maintaining a ‘buy’ rating in view of there still being a 13% upside in returns.

DBS Group shares are trading at S$24.42 per share as of Tuesday 03 March.

Trade DBS Groups shares and other Singapore blue-chip stocks with an IG account.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.